The adult mammalian heart possesses little regenerative potential following injury. Fibrosis due to activation of cardiac fibroblasts impedes cardiac regeneration and contributes to loss of contractile function, pathological remodelling and susceptibility to arrhythmias. Cardiac fibroblasts account for a majority of cells in the heart and represent a potential cellular source for restoration of cardiac function following injury through phenotypic reprogramming to a myocardial cell fate. Here we show that four transcription factors, GATA4, HAND2, MEF2C and TBX5, can cooperatively reprogram adult mouse tail-tip and cardiac fibroblasts into beating cardiac-like myocytes in vitro. Forced expression of these factors in dividing non-cardiomyocytes in mice reprograms these cells into functional cardiac-like myocytes, improves cardiac function and reduces adverse ventricular remodelling following myocardial infarction. Our results suggest a strategy for cardiac repair through reprogramming fibroblasts resident in the heart with cardiogenic transcription factors or other molecules.
The adult mammalian heart possesses little regenerative potential following injury. Fibrosis due to activation of cardiac fibroblasts impedes cardiac regeneration and contributes to loss of contractile function, pathological remodelling and susceptibility to arrhythmias. Cardiac fibroblasts account for a majority of cells in the heart and represent a potential cellular source for restoration of cardiac function following injury through phenotypic reprogramming to a myocardial cell fate. Here we show that four transcription factors, GATA4, HAND2, MEF2C and TBX5, can cooperatively reprogram adult mouse tail-tip and cardiac fibroblasts into beating cardiac-like myocytes in vitro. Forced expression of these factors in dividing non-cardiomyocytes in mice reprograms these cells into functional cardiac-like myocytes, improves cardiac function and reduces adverse ventricular remodelling following myocardial infarction. Our results suggest a strategy for cardiac repair through reprogramming fibroblasts resident in the heart with cardiogenic transcription factors or other molecules.
Heart disease caused by the loss or dysfunction of cardiomyocytes is the leading cause of death worldwide 1 . Whereas the neonatal mammalian heart can regenerate following injury 2 , the capacity for regeneration of adult mammalian hearts is limited 3 . A fundamental goal of regenerative cardiovascular medicine is to successfully repair injured hearts by replacing cardiomyocytes and decreasing fibrosis. Transplantation of cardiac stem cells or stem cell-derived cardiomyocytes to improve cardiac function holds clinical potential, but is relatively inefficient [4] [5] [6] .
Fibroblasts can be reprogrammed into pluripotent stem cells, muscle cells and neurons by combinations of lineage-enriched transcription factors [7] [8] [9] [10] [11] [12] . The human heart is composed of approximately 30% cardiomyocytes and 60-70% cardiac fibroblasts 13 . We sought to define the optimal combination of core cardiac transcription factors necessary and sufficient for reprogramming of adult fibroblasts into functional cardiomyocytes and to determine if these factors could improve cardiac function in injured hearts through reprogramming of endogenous cardiac fibroblasts. Here we show that four transcription factors, GATA4, HAND2, MEF2C and TBX5, are able to reprogram adult mouse fibroblasts into functional cardiac-like myocytes in vitro and in vivo, and expression of these factors in non-cardiomyocytes enhances function of injured hearts following myocardial infarction.
Reprogramming of adult fibroblasts into cardiac-like myocytes
A core set of evolutionarily conserved transcription factors (GATA4, HAND2, MEF2C, MESP1, NKX2-5 and TBX5) controls cardiac gene expression and heart development 14, 15 . Recently, GATA4, MEF2C and TBX5 were reported to be capable of converting neonatal fibroblasts to cardiomyocyte-like cells in vitro 16 . To search for an optimal combination of transcription factors capable of inducing cardiac lineage-reprogramming, we generated retroviruses to express each of the six core cardiac transcription factors (GATA4 (G), HAND2 (H), MEF2C (M), MESP1 (Ms), NKX2-5 (N), and TBX5 (T)) in fibroblasts derived from adult mice bearing a cardiac-specific a-MHC-GFP transgene, where the promoter of the a-myosin heavy chain gene controls the expression of green fluorescent protein ( Supplementary Figs 1 and 2) .
Potential cardiogenic activity of the six factors (G, H, M, Ms, N, T) in adult tail-tip fibroblasts (TTFs) from a-MHC-GFP transgenic mice was quantified by analysis of GFP 1 cells by flow cytometry 9 days after viral transduction. No GFP 1 cells were observed in fibroblast cultures transduced with viral backbone or without infection. However, the six factors together generated a small population of cells (,7%) positive for GFP ( Supplementary Fig. 3 ). After several rounds of withdrawing one factor, we identified several combinations, including GHMMsT, GHMT, HMMsT, GMT, HMT and MT, that were capable of efficiently inducing a-MHC-GFP 1 cells ( Supplementary  Fig. 3 ). The cooperativity amongst the different factors is consistent with their ability to synergistically activate cardiac gene expression and to activate each other's expression 14, [17] [18] [19] [20] .
To determine whether the above factors could activate endogenous cardiac-specific genes in adult TTFs, we examined expression of cardiac troponin T (cTnT, also known as TNNT2) and a-MHC-GFP by flow cytometry ( Supplementary Fig. 4 ). Depending on the experiment, GHMT induced between 5.2% and 19.7% (average 9.2%) of cells to become positive for both a-MHC-GFP and cTnT. We refer to GHMT-transduced cells expressing cardiomyocyte markers as induced cardiac-like myocytes (iCLMs). By comparison, GMT induced approximately 2.9% (1.5% to 5.6%) of adult TTFs to adopt a cTnT 1 a-MHC-GFP 1 phenotype ( Supplementary Fig. 4 ). The percentage of iCLMs generated from adult TTFs by GHMT (9.2%) was about fourfold higher than previously reported for neonatal TTFs with GMT (2.5%) 16 . The percentage of cells expressing cTnT and a-MHC-GFP reached a peak at day 7 of transduction; the fraction of iCLMs declined thereafter due to overgrowth of nonreprogrammed fibroblasts ( Supplementary Fig. 5 ).
Cardiac fibroblasts are the most prevalent interstitial cell type in adult mammalian hearts. We transduced adult cardiac fibroblasts with GHMT, GMT or empty viruses and analysed expression of cardiac markers by flow cytometry 1 week later. GHMT induced 6.8% of cardiac fibroblasts to become cTnT 1 a-MHC-GFP 1 , compared with 1.4% double-positive cells with GMT (Supplementary Fig. 6a ). GHMT induced both cTnT and cTnI (cardiac troponin I, also known as TNNI3) in 7.5% of cells ( Supplementary Fig. 6b ). Thus, GHMT represented the most optimal combination of factors for efficient initiation of cardiac gene expression in adult fibroblasts. a-MHC-GFP 1 cells derived from adult TTFs and cardiac fibroblasts by GHMT transduction showed strong immunostaining of the sarcomeric proteins a-actinin and cTnT (Fig. 1a, b and Supplementary Fig. 7 ). More organized sarcomeres were observed in iCLMs at day 30 ( Fig. 1b ) compared to day 14 (Fig. 1a ). In the presence of GHMT, three types of iCLMs, referred to as types A, B and C, which seem to represent a spectrum of cardiac reprogramming, were induced from adult cardiac fibroblasts and TTFs. Type A iCLMs only expressed a-MHC-GFP. Type B iCLMs expressed both a-MHC-GFP and a-actinin. Type C iCLMs not only expressed a-MHC-GFP and a-actinin, but also showed sarcomere-like structures ( Fig. 1a ). GHMT induced ,15% of adult cardiac fibroblasts and ,18% of adult TTFs to become a-MHC-GFP-positive cells, and ,30% and ,10% of these became type C iCLMs, respectively ( Fig. 1c ).
Microarray and quantitative PCR (qPCR) analysis of gene expression patterns showed expression of a broad range of cardiac genes, indicative of a cardiac-like phenotype, and concomitant suppression of non-myocyte genes including Fsp1 (fibroblast-specific protein 1 or S100A4) in fibroblasts transduced with GHMT ( Supplementary Figs 8  and 9 ). Following maintenance of GHMT-transduced adult cardiac fibroblasts or TTFs in culture for more than 5 weeks, we observed spontaneous contractions in approximately 0.2% of type C iCLMs. These beating iCLMs had calcium transients and action potentials (Supplementary Movies 1, 2 and 3, Fig. 1d and Supplementary Figs 10 and 11). iCLMs had a pattern of calcium transients most similar to neonatal ventricular cardiomyocytes ( Fig. 1d ). Transduction with inducible expression vectors showed that the cardiomyocyte-like phenotype was stable following termination of exogenous GHMT expression ( Supplementary Fig. 12 ). Co-staining for cardiomyocyte marker and Myc-tagged GHMT indicates that induction of the cardiomyocyte-like phenotype by GHMT is cell-autonomous (Supplementary Fig. 13 ). Together, these results indicate that GHMT can activate cardiac gene expression in a sub-population of TTFs and cardiac fibroblasts. The relatively small percentage of cells that adopts the cardiac-like phenotype perhaps indicates a precise stoichiometry or high level of the cardiac factors required for phenotypic conversion, which is achieved in only a fraction of cells, or to differential susceptibility to reprogramming amongst heterogeneous cell types in the starting non-myocyte population. The efficiency of cellular reprogramming to iCLMs by GHMT is comparable to that of reprogramming of induced pluripotent stem (iPS) cells by pluripotency factors 7, 21 .
Reprogramming of FSP1-tagged cells into iCLMs in vivo
Following myocardial infarction or other forms of cardiac injury, cardiomyocytes undergo necrotic and apoptotic cell death and cardiac fibroblasts are activated to produce collagen and other extracellular matrix components, causing fibrosis and impaired cardiac function 22 . Therefore, we sought to determine whether reprogramming cardiac fibroblasts to a cardiomyocyte fate might blunt the decline in cardiac function post-myocardial infarction. Adult mammalian cardiomyocytes do not divide and are therefore resistant to retroviral expression. We expressed the cardiogenic transcription factors in cardiac fibroblasts and other dividing cells in vivo using a retrovirus expression system, which is specific for proliferating cells and directs expression preferentially in myofibroblasts of injured rodent hearts 23 . We confirmed the specificity of retroviral infection for replicating non-cardiomyocytes by injecting concentrated GFP retroviruses into injured hearts after ligation of the left anterior descending coronary artery (LAD), which induces RESEARCH ARTICLE myocardial infarction. GFP expression was clearly detected in the ischaemic area. However, none of the GFP 1 cells expressed the cardiac marker, cTnT, consistent with the specificity of retroviral infection for proliferating non-cardiomyocytes ( Supplementary Fig. 14) . FSP1 is expressed in non-cardiomyocytes such as fibroblasts and transitioning epithelia [24] [25] [26] . In mouse and human hearts, expression of FSP1 primarily colocalizes with markers of cardiac fibroblasts and increases following myocardial infarction 26 . Non-cardiomyocytes in mice carrying alleles of Fsp1-Cre and Rosa26-LacZ are specifically labelled with b-galactosidase (b-gal), providing a marker for fibroblast lineage tracing 24 . To examine whether cardiac transcription factors were able to activate cardiac genes in non-cardiomyocytes in vivo, we performed LAD ligation on Fsp1-Cre/Rosa26-LacZ mice and injected concentrated retroviruses encoding GHMT or GFP into the border zone immediately following LAD ligation. We then analysed b-gal activity in histological sections of hearts at various times thereafter. In uninjured hearts, less than one b-gal 1 cardiomyocyte per section was observed. After injury, b-gal expression was readily detected in cardiac fibroblasts throughout the infarct zone ( Fig. 2a, b ). In injured hearts infected with GFP viruses, 0.05 6 0.13% of cardiomyocytes in the injured area were b-gal 1 (Fig. 2c ), which may be due to low-level ectopic activation or to a basal level of new cardiomyocyte formation from a stem cell pool, as reported previously 27 . In contrast, abundant clusters of intensely stained b-gal 1 cardiomyocytes were observed throughout the infarct and border zone of injured hearts infected with the GHMT retrovirus cocktail ( Fig. 2b ). We observed that 6.5 6 1.2% of cardiomyocytes in the injured area showed b-gal activity (Fig. 2c ). Generally, more b-gal 1 cardiomyocytes were observed in the border zone adjacent to the infarct region, which may be due to intact vascular structures or higher viral infection in this region. Similar results were obtained upon injection with GHMMsT, whereas the inclusion of NKX2-5 (GHMMsNT) diminished the efficacy of the other five factors ( Supplementary Fig. 15 ), as seen in vitro. b-gal 1 cardiomyocytes expressed cTnT and showed clear striations 3 weeks after viral transduction ( Fig. 2b ). Through quantification of b-gal 1 cardiomyocytes in histological sections of infarcted hearts, we calculated that at least 10,000 new myocytes were generated in the injured area after 3 weeks of GHMT infection. This is likely to be an underestimate of the number of iCLMs generated in vivo because the reporter is only expressed in a subset of non-myocytes, such that unmarked cells could also be reprogrammed but go undetected.
In the heart, gap junctions composed of connexins ensure electrical and metabolic coupling between cardiomyocytes and coordinate their contractility 28 . To determine whether reprogrammed cardiomyocytes could couple with surrounding endogenous myocytes through gap junctions, we performed immunostaining for connexin 43 (Cx43, also known as GJA1), the major connexin in functional cardiomyocytes 29 . Gap junctions were observed between b-gal 1 and b-galcardiomyocytes and between b-gal 1 cardiomyocytes (Fig. 2d ), indicating coupling of reprogrammed cardiomyocytes with surrounding myocytes. Reprogrammed b-gal 1 cardiomyocytes isolated from ventricular myocardium and identified by labelling with a fluorogenic, lipophilic b-gal substrate (C 12 FDG) also had a pattern of contractility and calcium transients similar to normal b-galventricular cardiomyocytes in response to electrical pacing at 1 Hz ( Fig. 2e ), indicating their functionality.
Reprogramming of TCF21-tagged cells into iCLMs in vivo
To rule out the possibility that injury or viral infection might somehow activate the Fsp1 reporter in cardiomyocytes, we generated a strain of mice harbouring an inducible MerCreMer expression cassette inserted by homologous recombination into the Tcf21 (also known as capsulin or epicardin) locus (Tcf21 iCre ), which is expressed specifically in noncardiomyocytes in the heart ( Supplementary Fig. 16 ) 30 . Intercrossing of these mice with mice bearing the Cre-inducible R26R tdTomato reporter showed specific expression of Tomato predominantly in cardiac fibroblasts with less expression in endothelial cells ( Supplementary Fig. 16 ). 
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However, we only observed one Tomato 1 cardiomyocyte in over 40 histological sections of normal hearts. Tcf21 iCre R26R tdT mice were treated with tamoxifen for 3 days to mark TCF21-expressing cells. Eight days after the last tamoxifen treatment, LAD ligation was performed and animals were injected with empty vector, GFP or GHMT retroviruses and analysed 3-4 weeks later. Numerous Tomato 1 cardiomyocytes were observed in GHMT-injected hearts compared to GFP-injected ones (Fig. 3a) .
To quantify Tomato 1 cardiomyocytes, we isolated cardiomyocytes from intact hearts using the Langendorff perfusion method. In GHMT-injected hearts, 2.4 6 1.5% of cardiomyocytes in the injured area were Tomato 1 , and these Tomato 1 cardiomyocytes showed clear striations (Fig. 3b, c) . However, in empty vector-injected injured hearts, only 0.004 6 0.005% of cardiomyocytes were Tomato 1 (Fig. 3c) . Tcf21 iCre marks a smaller, more restricted fraction of nonmyocytes than Fsp1-Cre. Hence the number of new myocytes marked with this reporter is lower than with Fsp1-Cre. These findings indicate that forced expression of GHMT in non-myocytes of the heart is sufficient to induce the expression of cardiac markers. The Tomato 1 cardiomyocytes induced by GHMT in vivo were able to spontaneously contract in vitro ( Supplementary Fig. 17 and Supplementary Movie 4). Recording of action potentials of reprogrammed Tomato 1 cardiomyocytes and endogenous cardiomyocytes by whole-cell patch clamping indicated functionality of cardiomyocytes induced by GHMT in vivo (Fig. 3d) .
To further test whether GHMT indeed promoted the formation of new cardiomyocytes following myocardial infarction, and to rule out the possibility that labelled cardiomyocytes obtained from Fsp1-Cre or Tcf21 iCre /Rosa marker mice injected with GHMT might arise from fusion of native cardiomyocytes with non-myocytes, we used mice with an inducible a-MHC-MerCreMer transgene and Rosa26-LacZ reporter. Gavage of these mice with tamoxifen for seven consecutive days resulted in labelling of 87.7 6 1.9% of cardiomyocytes in the left ventricular myocardium. Following LAD ligation and injection of GFP retroviruses, we observed a reduction in the percentage of b-gal-labelled cardiomyocytes (83.2 6 4.6%) in the border zone adjacent to the infarct, indicating replenishment of cardiomyocytes following injury, as described previously 27, 31 . Injection of GHMT retroviruses further reduced the percentage of b-gal 1 cardiomyocytes in the border zone (76.0 6 5.2%) ( Supplementary Fig. 18 ). These findings indicate that GHMT promotes the formation of new cardiomyocytes from a non-a-MHC lineage in vivo following injury.
Enhancement of cardiac regeneration of injured hearts
We examined whether forced expression of GHMT in noncardiomyocytes could lead to measurable improvement in function of ischaemic hearts. Cardiac function following myocardial infarction was assessed in a blinded fashion by fractional shortening , ejection fraction and stroke volume using echocardiography and magnetic resonance imaging (MRI). Twenty-four hours after LAD ligation, fractional shortening and ejection fraction assessed by echocardiography of all mice decreased relative to sham-operated mice. Thereafter, cardiac function of GFP-injected mice continued to decline, reaching a stable value 2 weeks post-myocardial infarction; fractional shortening < 13% and ejection fraction < 30%. In contrast, infection of injured myocardium with GHMT retroviruses blunted further worsening of cardiac function 3 weeks post-myocardial infarction; fractional shortening < 26% and ejection fraction < 51% (Fig. 4a ). By comparison, functional improvement was delayed and less complete with GMT, consistent with the reduced efficiency of this transcription factor combination in reprogramming in vitro.
To determine whether functional improvement was sustained, we assessed cardiac function at 6 weeks and 12 weeks by ejection fraction and stroke volume using cardiac MRI. Ejection fraction of GFPinjected mice decreased to reach a stable value of approximately 28% 6 weeks post-myocardial infarction (Fig. 4b) . In contrast, infection of injured myocardium with GHMT blunted worsening of ejection fraction 6 weeks post-myocardial infarction (,49%) with further significant improvement at 12 weeks post-myocardial infarction (,57%) ( Fig. 4b ). This long-term effect on ejection fraction by GHMT was accompanied by significant increases in stroke volume at 12 weeks compared to 6 weeks (Fig. 4b ). Individual mice in each group demonstrated similar functional changes in both cardiac parameters, indicating the reliability of cardiac MRI to assess cardiac function ( Supplementary Fig. 19 ). These data indicate that expression of GHMT in non-cardiomyocytes in injured hearts can sustain cardiac function. Moreover, GHMT-and GHMMsT-infected hearts showed a pronounced reduction in fibrosis and increased muscle tissue, compared with GFP-infected hearts after myocardial infarction (Fig. 5a, b and Supplementary Fig. 20) . of heart sections isolated from tamoxifen-treated Tcf21 iCre /Rosa26R tdT mice that were subjected to LAD ligation followed by injection of GFP or GHMT retroviruses. Three weeks post-myocardial infarction, hearts were fixed, sectioned and stained for cTnT (green) and visualized for tomato (red). Upper panels show GFP-injected heart in which tomato is seen only in fibroblasts. Lower panels show GHMT-injected heart in which tomato is seen in both fibroblasts and cardiomyocytes. Three types of iCLMs (positive for cTnT and tomato) were observed in injured hearts injected with GHMT-virus: cell A, small cells without sarcomeres; cell B, has sarcomeres and expresses equivalent cTnT to neighbouring tomato-negative cardiomyocytes; cell C, has sarcomeres and expresses less cTnT than neighbouring tomato-negative cardiomyocytes. Scale bars, 20 mm. b, Tomato 1 iCLMs isolated from tamoxifen-treated Tcf21 iCre /Rosa26R tdT mice 1 month post-myocardial infarction followed by injection of GHMT retroviruses. Scale bar, 20 mm. c, Quantification of tomato 1 cardiomyocytes isolated from uninjured hearts (n 5 2), injured hearts treated with empty vector retroviruses (n 5 3), or GHMT retroviruses (n 5 3). Data are presented as mean 6 s.d. d, Recording of action potential of tomato 1 iCLMs and endogenous cardiomyocytes by patch-clamping. Action potentials were recorded in response to brief (1-2 ms) depolarizing current (1-2 nA) injections delivered at 1 Hz by whole-cell current patch-clamping. (n 5 5 for each group).
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Discussion
Our results demonstrate that GATA4, HAND2, MEF2C and TBX5 (GHMT) can reprogram cardiac fibroblasts into functional cardiaclike myocytes in vitro and in vivo, confirming and extending prior studies 16 . Moreover, exogenous GHMT expression in noncardiomyocytes of the heart post-myocardial infarction also reduces fibrosis and improves cardiac function. Improvement of cardiac function post-myocardial infarction by different transcription factor combinations correlated with their ability to convert fibroblasts into iCLMs in vitro ( Supplementary Fig. 21 ), suggesting that cardiac repair results, at least in part, from reprogramming of non-cardiomyocytes towards a cardiomyocyte fate. We feel it is important to emphasize, however, that the pronounced functional improvement of GHMT-injected hearts seems greater than might be predicted from the relative inefficiency of reprogramming of adult cardiac fibroblasts to iCLMs in vitro. We speculate that the native milieu of the intact heart, containing extracellular matrix, growth factors, persistent contractility, surrounding contractile cells and other cell types, is more permissive than plastic tissue culture dishes for functional reprogramming. In this regard, reprogramming of pancreatic beta-cells has been observed in vivo but not in vitro 32 . It is also conceivable that other mechanisms, such as a blockade to the activation of cardiac fibroblasts, enhanced survival of cardiomyocytes, facilitated differentiation of activated cardiac progenitors into cardiomyocytes, as described previously 27, 31 , or improved angiogenesis contribute to the benefits observed upon expression of GHMT in the heart post-myocardial infarction. Irrespective of these uncertainties, the strategy presented here, while still requiring optimization, provides a potential means of improving cardiac function in vivo, bypassing many of the obstacles associated with cellular transplantation.
METHODS SUMMARY
All experimental procedures with animals were approved by the Institutional Animal Care and Use Committee at University of Texas Southwestern Medical Center.
Adult TTFs and cardiac fibroblasts were isolated by an explanting method in which fibroblasts migrate from minced tissue and grow in fibroblast growth medium. Fibroblasts were transduced with a mixture of polybrene (Sigma; 6 mg ml 21 ) and freshly made retroviruses expressing transcription factors generated in Platinum E cells (Cell Biolabs). Twenty-four hours after viral transduction, the viral medium was changed to a cardiac induction medium. Medium was changed every 2 days. Expression of cardiac genes was analysed by flow cytometry, microarray and immunocytochemistry.
Adult 
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function was assessed using echocardiography and MRI. Hearts were collected from euthanized animals for histological studies.
Isolation of cardiomyocytes, electrophysiological measurements, histology and immunohistochemistry were performed as described previously 2,33-37 .
METHODS
Isolation of primary fibroblasts. Tail-tip fibroblasts (TTFs): adult mouse tails were skinned and cut into small pieces which were plated on tissue culture dishes and cultured in DMEM supplemented with 15% FBS and antibiotics. The medium was changed every 2 to 3 days. TTFs migrated out from the explants after 2 or 3 days. One week later, TTFs were frozen or replated for viral transduction.
Cardiac fibroblasts: hearts from adult mice (older than 4 weeks of age) were minced into small pieces and plated on tissue culture dishes. Three minutes later, culture medium (DMEM:199 (4:1), 15% FBS and antibiotics) was gently added to the dishes. Cardiac fibroblasts started to migrate out of the minced heart tissue after 2 days. The medium was replaced every 2 days. Ten days later, cardiac fibroblasts were frozen or replated for viral transduction. Generation of retroviruses. Retroviral plasmid DNA was generated by subcloning EGFP, Myc-tagged NKX2-5, GATA4, TBX5, HAND2, MEF2C and Flagtagged MESP1 complementary DNAs into the retroviral vector pBabe-X 38 .
Ten micrograms of retroviral plasmid DNA was transfected using FuGENE 6 (Roche) into Platinum E cells (Cell Biolabs) which were plated on a 10-cm tissue culture dish at a density of 3 3 10 6 cells per dish, 24 h before transfection. Twelve hours after transfection, medium was changed to 12 ml of fresh medium (DMEM supplemented with 10% FBS and antibiotics). After 36 h of transfection, viral medium was harvested and filtered through a 0.45 mm cellulose filter. The viral supernatant was mixed with polybrene (Sigma) to a final concentration of 6 mg ml 21 . Viral transduction. TTFs and cardiac fibroblasts were plated on tissue culture dishes pre-coated with SureCoat (Cellutron) at a density of 0.8 3 10 4 cm 22 . After 24 h, the fibroblast growth medium was replaced with freshly made viral mixture containing polybrene. Twenty four hours later, viral medium was replaced with induction medium, composed of 10% conditioned medium obtained from neonatal rat/mouse cardiomyocyte culture, DMEM/199 (4:1), 10% FBS, 5% horse serum, antibiotics, non-essential amino acids, essential amino acids, B-27, insulin-selenium-transferrin, vitamin mixture, and sodium pyruvate (Invitrogen). Conditioned medium was filtered through a 0.22-mm pore size cellulose filter. Medium was changed every 2 days until cells were collected. qPCR, western blot analysis and immunocytochemistry. Total RNA was extracted from cultured cells and cDNA was synthesized by reverse transcription. All qPCR probes were obtained from Applied Biosystems. Western blots were performed with anti-Myc (Santa Cruz, clone A-14 1:1,000) and anti-Flag (Sigma, 1:2,000) antibody. For immunocytochemistry, cells were fixed in 4% paraformaldehyde and incubated with primary antibodies: anti-GFP (Torrey Pines Biolabs 1:400), anti-cTnT (Thermo Scientific 1:400), anti-Myc (Santa Cruze, clone A-14 1:200), and anti-a-actinin (Sigma, 1:400). After washing with PBS, Alexa fluorogenic secondary antibodies (Invitrogen) were used to detect the signal. DNA microarray. Total RNA was isolated from uninfected cardiac fibroblasts, cardiac fibroblasts transduced with either empty vector or GHMT retroviruses and adult heart. Microarray analysis was performed on the platform of Illumina Mouse-6 Beadchip by the DNA Microarray Core Facility at the University of Texas Southwestern Medical Center. Data were analysed using GeneSpring GX software (Agilent). Flow cytometry. For the initial assay to detect aMHC-GFP expression, adherent fibroblasts were washed with PBS and detached from culture dish by treatment with Accutase (Millipore) for 10 min at 37 uC. Cells were then washed with 2% FBS in PBS and filtered through a cell strainer. Cells were incubated with propidium iodide (1:1,000 dilution in 1% FBS in PBS) for 15 min at room temperature. Dead cells were excluded by propidium iodide staining and live cells were analysed for GFP expression using FACS Caliber (BD Sciences) and FlowJo software.
For intracellular staining of cardiac-specific markers, cells were fixed with 4% paraformaldehyde for 15 min after being harvested, as described above. Fixed cells were washed with PBS and permeabilized with saponin for 10 min at room temperature. After being washed with PBS, cells were incubated with 5% goat and donkey serum in PBS at room temperature for 30 min, followed by incubation with primary antibodies (rabbit polyclonal anti-GFP antibody (Invitrogen) at a 1:100 dilution and mouse monoclonal anti-cTnT antibody (Thermo Scientific) at a 1:400 dilution in 0.2% goat and donkey serum in PBS for 30 min at room temperature. After washing twice with PBS, cells were incubated with secondary antibodies for 30 min at room temperature. Secondary antibodies were goat anti-rabbit Alexa Fluor 488 (Invitrogen) at a 1:200 dilution and donkey anti-mouse Cy5 (Jackson Laboratory) at a 1:400 dilution in PBS containing 0.2% goat and donkey serum. Cells were washed with PBS three times, and then analysed for GFP and cTnT expression using FACS Caliber (BD Sciences) and FlowJo software. Generation of a-MHC-GFP transgenic mice. A plasmid containing a 5.5 kilobase genomic fragment upstream of the mouse a-MHC gene plus exons 1-3 and intronic sequences 39 , inserted upstream of a neomycin-resistance cassette followed by an internal ribosomal entry sequence (IRES) and a GFP reporter was linearized and micro-injected into the pronucleus of zygotes. The founders were crossed to C57BL/6 mice to get stable lines. Induction of Cre by tamoxifen administration. Tamoxifen (Sigma) was dissolved in sesame oil (90%) and ethanol (10%) at a concentration of 50 mg ml 21 . To induce Cre activity, tamoxifen (0.2 mg g 21 body weight) was administered by gavage with a 22-gauge feeding needle into mice bearing Tcf21 iCre/1 /R26R tdT or a-MHC-MerCreMer 40 /Rosa26-LacZ for three to five or seven consecutive days, respectively. Mice were analysed or subjected to myocardial infarction surgery at day 8 post-oral gavage of the last dosage. Sorting of Tcf21-expressing cells and gene expression. Three-month-old Tcf21 iCre/1 /R26R tdT mice were induced with 0.2 mg g 21 tamoxifen for 3 consecutive days by gavage, and 1 week later hearts were isolated and processed (atria and aorto-pulmonary trunk were removed) to generate single cell suspensions for FACS sorting, as described previously 41 . The suspension was filtered through tissue strainers, centrifuged at 400g for 5 min and resuspended in 10% CM media (10% Hyclone FBS, 3:1 DMEM/M-199, 10 mM HEPES, 1.2% antibiotic/antimycotic) before sorting with a MoFlo flow cytometer (Cytomation) using Summit software. For transcript analysis, sorted cells were collected into lysis buffer for RNA extraction (RNAqueous Micro kit from Ambion). A fraction of each sample was also collected into PBS for post-sort assessment of purity. Complementary DNA was synthesized using Superscript III reverse transcriptase (Invitrogen) and random hexamers (Roche). Gene expression profiles were generated using standard qPCR methods with iTAQ SYBR Green master mix (Bio-Rad) on a CFX96 instrument (Bio-Rad). Samples were run in triplicate and normalized to cyclophilin expression. Fold enrichment was determined with respect to the unsorted population.
Myocardial infarction surgery and intramyocardial injection of retroviruses.
Mice were anesthetized with isoflurane, intubated with a polyethylene tube (size 60), and then ventilated with a volume-cycled rodent respirator with 2-3 ml per cycle at a respiratory rate of 120 cycles per min. Thoracotomy was performed at the third intercostal space and self-retaining microretractors were placed to separate the third and fourth rib to visualize the LAD. A 7.0 prolene suture (Ethicon, Johnson & Johnson) was then passed under the LAD at 1.5 mm distal to the left atrial appendage, immediately after the bifurcation of the left main coronary artery. The LAD was doubly ligated. The occlusion was confirmed by the change of colour (becoming paler) of the anterior wall of the left ventricle. Sham-operated mice underwent the same procedure without ligation. Immediately after ligation of the LAD, 50 ml of concentrated retrovirus (,10 8 -10 9 infectious units (i.f.u.)) was injected into the border zone of the infarct at five different areas using a gastight 1710 syringe (Hamilton). The chest wall was then closed with a 5.0 Dexon absorbable suture (Tyco Healthcare, United States Surgical), and the skin was closed with Topical Tissue Adhesive (Abbott Laboratory). Mice were extubated and allowed to recover from surgery under a heating lamp. The mouse surgeon was blinded to the study. Mice with fractional shortening .30% at day 1 postmyocardial infarction were removed from the study. Transthoracic echocardiography. Cardiac function was evaluated by twodimensional transthoracic echocardiography on conscious mice using a VisualSonics Vevo2100 imaging system. Fractional shortening and ejection fraction were used as indices of cardiac contractile function. M-mode tracings were used to measure left ventricular internal diameter at end diastole (LVIDd) and end systole (LVIDs). Fractional shortening (FS) was calculated according to the following formula: FS (%) 5 [(LVIDd -LVIDs)/LVIDd] 3 100. Ejection fraction (EF) is estimated from [(LVEDV 2 LVESV)/LVEDV] 3 100%. LVESV, left ventricular end systolic volume; LVEDV, end diastolic volume. All measurements were performed by an experienced operator blinded to the study. Cardiac MRI. Six and twelve weeks after myocardial infarction, the cardiac function of mice was re-evaluated by cardiac MRI using a 7 T small animal MR scanner (Varian) with a 38-mm birdcage RF coil. Under anaesthesia by inhalation of 1.5-2% isoflurane mixed with medical-grade air via nose-cone, the animals were placed prone on a mouse sled, (Dazai Research Instruments) equipped with a pneumatic respiratory sensor and electrocardiogram (ECG) electrodes for cardiac sensing, head first with the heart centred with respect to the centre of the RF coil. The mouse chests were shaved and a conducting gel was applied to optimize ECG contact between electrodes and mouse. All MRI acquisitions were gated using both cardiac and respiratory triggering. The bore temperature was kept at 35 uC to assure adequate and constant heart rate.
Two-dimensional (2D) gradient echo images on three orthogonal planes (transverse, coronal and sagittal) were acquired to determine the long-axis of the heart in each mouse. Axial images perpendicular to the long axis of the heart were chosen for cine-imaging. Cine images at 12 phases per cardiac cycle were obtained with an echo time of 2.75 ms, repetition time 5 ECG R-R interval /12, flip angle of 45u, and number of excitation (NEX) 5 4. Each scan consisted of seven to ten contiguous slices from apex to LV outflow with 1-mm thickness, a matrix size of 128 3 128, and a field of view of 30 3 30 mm.
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